Ritsuko Komaki

19.4k total citations · 2 hit papers
163 papers, 9.3k citations indexed

About

Ritsuko Komaki is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ritsuko Komaki has authored 163 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Pulmonary and Respiratory Medicine, 56 papers in Oncology and 51 papers in Surgery. Recurrent topics in Ritsuko Komaki's work include Lung Cancer Diagnosis and Treatment (78 papers), Lung Cancer Treatments and Mutations (62 papers) and Esophageal Cancer Research and Treatment (44 papers). Ritsuko Komaki is often cited by papers focused on Lung Cancer Diagnosis and Treatment (78 papers), Lung Cancer Treatments and Mutations (62 papers) and Esophageal Cancer Research and Treatment (44 papers). Ritsuko Komaki collaborates with scholars based in United States, Canada and China. Ritsuko Komaki's co-authors include James D. Cox, Zhongxing Liao, Stephen G. Swisher, Jaffer A. Ajani, Jack A. Roth, Arlene M. Correa, Roger W. Byhardt, Joe Y. Chang, Pamela K. Allen and Walter J. Curran and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Ritsuko Komaki

160 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer

1995 541 citations Ritsuko Komaki et al. profile →
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer

2019 352 citations Jeffrey D. Bradley, Chen Hu et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ritsuko Komaki United States	54	7.5k	3.1k	2.7k	2.2k	2.1k	163	9.3k
Umberto Ricardi Italy	48	4.8k 0.6×	2.7k 0.9×	2.3k 0.9×	2.3k 1.1×	2.4k 1.2×	362	10.0k
André Konski United States	44	4.5k 0.6×	3.7k 1.2×	3.5k 1.3×	1.7k 0.8×	1.3k 0.6×	228	8.8k
Sucha O. Asbell United States	43	7.9k 1.0×	2.5k 0.8×	3.0k 1.1×	2.0k 0.9×	1.2k 0.6×	120	10.1k
Pamela K. Allen United States	56	7.5k 1.0×	4.6k 1.5×	3.9k 1.4×	2.0k 0.9×	1.8k 0.9×	289	12.5k
Kazushige Hayakawa Japan	32	5.5k 0.7×	2.0k 0.7×	1.1k 0.4×	2.1k 0.9×	2.0k 0.9×	194	7.4k
William T. Sause United States	50	8.3k 1.1×	4.7k 1.5×	2.3k 0.9×	2.3k 1.1×	1.8k 0.9×	173	12.3k
Daniel R. Gomez United States	47	4.3k 0.6×	3.1k 1.0×	1.6k 0.6×	1.2k 0.5×	2.2k 1.0×	260	8.1k
Carsten Nieder Norway	41	4.1k 0.5×	2.4k 0.8×	1.4k 0.5×	1.1k 0.5×	1.7k 0.8×	365	7.1k
F. Mornex France	40	3.7k 0.5×	3.0k 1.0×	2.5k 0.9×	1.1k 0.5×	1.1k 0.6×	272	7.0k
Clifford G. Robinson United States	47	5.2k 0.7×	1.8k 0.6×	1.1k 0.4×	3.2k 1.4×	3.1k 1.5×	310	8.6k

Countries citing papers authored by Ritsuko Komaki

Since Specialization

Citations

This map shows the geographic impact of Ritsuko Komaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritsuko Komaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritsuko Komaki more than expected).

Fields of papers citing papers by Ritsuko Komaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritsuko Komaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritsuko Komaki. The network helps show where Ritsuko Komaki may publish in the future.

Co-authorship network of co-authors of Ritsuko Komaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ritsuko Komaki. A scholar is included among the top collaborators of Ritsuko Komaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritsuko Komaki. Ritsuko Komaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weidhaas, Joanne B., Chen Hu, Ritsuko Komaki, et al.. (2023). The Inherited KRAS -variant as a Biomarker of Cetuximab Response in NSCLC. Cancer Research Communications. 3(10). 2074–2081. 1 indexed citations

Scheurer, Michael E., Renke Zhou, Mark R. Gilbert, et al.. (2022). Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825. Neuro-Oncology Advances. 4(1). vdac152–vdac152.

Komaki, Ritsuko, Jeremy J. Erasmus, Junya Fujimoto, Reza J. Mehran, & James D. Cox. (2018). Definition and Management of Superior Sulcus Tumors. 1(2). 37–57. 2 indexed citations

Adams, Daniel L., Diane K. Adams, Jianzhong He, et al.. (2017). Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy. Clinical Cancer Research. 23(19). 5948–5958. 80 indexed citations

Amini, Arya, Jaffer A. Ajani, Ritsuko Komaki, et al.. (2013). Factors Associated with Local–Regional Failure After Definitive Chemoradiation for Locally Advanced Esophageal Cancer. Annals of Surgical Oncology. 21(1). 306–314. 24 indexed citations

Evans, Jaden D., Daniel R. Gomez, Arya Amini, et al.. (2013). Aortic dose constraints when reirradiating thoracic tumors. Radiotherapy and Oncology. 106(3). 327–332. 47 indexed citations

Gomez, Daniel R., Gregory W. Gladish, Wei Xiong, et al.. (2012). Prognostic Value of Positron Emission Tomography/Computed Tomography Findings in Limited-stage Small Cell Lung Cancer Before Chemoradiation Therapy. American Journal of Clinical Oncology. 37(1). 77–80. 13 indexed citations

Zhang, Zhen, Chen Yuan, Yanzhi Chen, et al.. (2009). Outcomes with Esophageal Cancer Radiation Therapy. Journal of Thoracic Oncology. 4(7). 880–888. 3 indexed citations

Bruzzi, John F., Ritsuko Komaki, Garrett L. Walsh, et al.. (2008). Imaging of Non–Small Cell Lung Cancer of the Superior Sulcus. Radiographics. 28(2). 551–560. 21 indexed citations

10.

Grosshans, David R., et al.. (2007). Neurocognitive function in patients with small cell lung cancer. Cancer. 112(3). 589–595. 104 indexed citations

11.

Swisher, Stephen G., Jaffer A. Ajani, Arlene M. Correa, et al.. (2006). The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer. 106(5). 1017–1025. 101 indexed citations

12.

Wang, Shulian, Zhongxing Liao, Chen Yuan, et al.. (2006). Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience. Journal of Thoracic Oncology. 1(3). 252–259. 64 indexed citations

13.

Lee, J. Jack, B. Nebiyou Bekele, Xian Zhou, et al.. (2006). Decision Analysis for Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer. Journal of Clinical Oncology. 24(22). 3597–3603. 50 indexed citations

14.

Swisher, Stephen G., Wayne L. Hofstetter, Tsung Teh Wu, et al.. (2005). Proposed Revision of the Esophageal Cancer Staging System to Accommodate Pathologic Response (pP) Following Preoperative Chemoradiation (CRT). Annals of Surgery. 241(5). 810–820. 129 indexed citations

15.

Swisher, Stephen G., Joe B. Putnam, Arlene M. Correa, et al.. (2002). Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. Journal of Thoracic and Cardiovascular Surgery. 123(1). 175–183. 198 indexed citations

16.

Liao, Zhongxing, et al.. (2002). Induction chemotherapy increased survival of patients with cancer of the esophagus treated with preoperative chemoradiation followed by surgery. International Journal of Radiation Oncology*Biology*Physics. 54(2). 250–250. 3 indexed citations

17.

Mason, K.A., Ritsuko Komaki, James D. Cox, & Luka Milas. (2001). Biology-based combined-modality radiotherapy: workshop report. International Journal of Radiation Oncology*Biology*Physics. 50(4). 1079–1089. 17 indexed citations

18.

Nag, Subir, Jason F. Kelly, John L. Horton, Ritsuko Komaki, & Dattatreyudu Nori. (2001). Brachytherapy for carcinoma of the lung.. PubMed. 15(3). 371–81. 32 indexed citations

19.

Kupelian, Patrick A., Ritsuko Komaki, & Pamela Allen. (1996). Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. International Journal of Radiation Oncology*Biology*Physics. 36(3). 607–613. 90 indexed citations

20.

Komaki, Ritsuko, et al.. (1994). Treatment of node-negative non-small cell lung carcinoma (NSCLC) with radiotherapy alone. Lung Cancer. 11. 140–140. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact